CX Institutional’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$156K Sell
1,192
-940
-44% -$141K ﹤0.01% 794
2026
Q2
$325K Buy
2,132
+1,279
+150% +$213K 0.01% 597
2026
Q1
$179K Sell
853
-258
-23% -$64.8K 0.01% 748
2025
Q4
$316K Buy
1,111
+52
+5% +$16.3K 0.01% 561
2025
Q3
$327K Buy
1,059
+66
+7% +$20.7K 0.01% 544
2025
Q2
$312K Buy
993
+106
+12% +$30.6K 0.01% 494
2025
Q1
$233K Sell
887
-26
-3% -$7.04K 0.01% 548
2024
Q4
$238K Buy
+913
New +$230K 0.01% 483
2021
Q4
– Sell
-4
Closed -$1K – 764
2021
Q3
$1K Hold
4
– – ﹤0.01% 947
2021
Q2
$1K Buy
+4
New +$1.09K ﹤0.01% 943
2021
Q1
– Sell
-3
Closed -$1K – 880
2020
Q4
$1K Buy
+3
New +$744 ﹤0.01% 849

Other funds holding PODD

CX Institutional's PODD Position: Q3 2026 in Review

CX Institutional reduced its Insulet (PODD) stake by 44% in Q3 2026, selling an estimated $141K and leaving 1,192 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

CX Institutional first reported a position in PODD in Q4 2020 and has held it in 11 quarters since. The position peaked at $327K in Q3 2025. 95 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • CX Institutional held 1,192 shares of Insulet worth $156K as of Q3 2026.
  • CX Institutional sold 940 Insulet shares in Q3 2026, an estimated $141K.
  • Insulet made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #794 holding.
  • CX Institutional first reported a position in Insulet in Q4 2020 and has held it in 11 quarters since.
  • CX Institutional's Insulet position peaked at $327K in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.